Facebook
Twitter
LinkedIn
ForwardVirtual Symposium - Assessing the Role of TAVR Across the Risk Continuum: Emerging Evidence, Evolving Guidance, and Expert Perspectives
Aortic stenosis (AS) is a fatal disease if not treated promptly, especially in the older population.
Category
- CMHC
Format
- Video
Credits
- ACPE Pharmacy
- AMA PRA Category 1 Credit™
- ANCC
- CDE
- Participation
Virtual Symposium: CGM - Going Beyond HbA1c to Optimize and Individualize T2D Management
Measuring HbA1c has been the method of choice to assess glucose control; however, it does not reflect potential glucose excursions leading to hypoglycemia or postprandial hyperglycemia, which increase the risk of long-term complications, as well as overall glycemic variability.
Category
- CMHC
Format
- Video
Credits
- ACPE Pharmacy
- AMA PRA Category 1 Credit™
- ANCC
- CDE
- Participation
Webcast: Challenging Cases in Patients with Iron Deficiency and Heart Failure
Addressing iron deficiency (ID) in patients with heart failure (HF) has become an important aspect of optimizing guideline-directed care in HF, as outlined by recent evidence and updated guidelines.
Category
- CMHC
Format
- Video
- Webinar recorded
Credits
- ACPE Pharmacy
- AMA PRA Category 1 Credit™
- ANCC
- Participation
Webcast: Advances in Screening, Diagnosis, and Treatment of Iron Deficiency in Heart Failure Patients
Iron deficiency (ID) with or without anemia is a common and important comorbidity in patients with heart failure (HF), and it can have significant impacts on morbidity and mortality. Despite this burden, the diagnosis and assessment of ID is not widely sought by clinicians that see patients with
Category
- CMHC
Format
- Video
- Webinar recorded
Credits
- ACPE Pharmacy
- AMA PRA Category 1 Credit™
- ANCC
- Participation
Clinical Brief: Should Diabetes Management be More Adipose-centric?
The co-occurrence of diabetes and obesity is now commonly termed “diabesity”- a new worldwide epidemic.
Category
- CMHC
Format
- Monograph
Credits
- ACPE Pharmacy
- AMA PRA Category 1 Credit™
- ANCC
- CDE
- Participation
CMHC Masterclass On Demand: Connecting the Dots in Cardiometabolic Medicine - Integrative Approaches to Improve Patient Care
Utilizing thought-provoking and interactive discussions, multidisciplinary experts in this masterclass cover advances in lifestyle, nutrition, genetics, and pharmacotherapy to prevent and address obesity, cardiovascular disease, hypertension, dyslipidemia, type 2 diabetes, kidney disease and more
Category
- CMHC
Format
- Conference / meeting
- Video
Credits
- ACPE Pharmacy
- AMA PRA Category 1 Credit™
- ANCC
- CDE
- Participation
Digital Pathway: Challenges and Advances in the Diagnosis and Management of Immune Thrombocytopenic Purpura
Immune thrombocytopenic purpura (ITP) is an autoimmune bleeding disorder that is characterized by suboptimal platelet count, purpura and hemorrhage.
Category
- CMHC
- TME
Format
- Self-study / Enduring
Credits
- ACPE Pharmacy
- AMA PRA Category 1 Credit™
- ANCC
- Participation
Clinical Brief: The Disproportionate Burden of ATTR-CM In African Americans
ATTR cardiac amyloidosis (ATTR-CM) is a complex disease that remains challenging to diagnose and treat, and disproportionally affects African American patients.
Category
- CMHC
Format
- Monograph
Credits
- ACPE Pharmacy
- AMA PRA Category 1 Credit™
- ANCC
- CDE
- Participation
Digital Pathway - Changing The Treatment Paradigm for LDL-C Lowering Post-MI: The Case for Early, ‘High-Intensity Lipid Lowering Therapy’ to Improve Outcomes
Patients with a recent myocardial infarction (MI) are at very high-risk for future atherosclerotic cardiovascular disease (ASCVD) events, however, targeted LDL-C goal achievement and optimization of lipid lowering therapy (LLT) in these patients remains suboptimal.
Category
- CMHC
Format
- Monograph
Credits
- ACPE Pharmacy
- AMA PRA Category 1 Credit™
- ANCC
- CDE
- Participation
Digital Pathway - Bridging the Frontiers of Care in Patients with T2D and CKD: Interpreting the Data with Novel MR Antagonists to Improve Cardiorenal Outcomes
Recent advances in the understanding of CKD progression in patients with type 2 diabetes have opened up new avenues of treatment that can potentially address some of the challenges and decrease cardiorenal risk in these patients.
Category
- CMHC
Format
- Monograph
Credits
- ACPE Pharmacy
- AMA PRA Category 1 Credit™
- ANCC
- CDE
- Participation